NCOA3 coactivator is a transcriptional target of XBP1 and regulates PERK–eIF2α–ATF4 signalling in breast cancer

Por Gupta, A, Hossain, M M, Miller, N, Kerin, M, Callagy, G, Gupta, S
Publicado no Oncogene (2016)

A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples

Por Chin, S-F, Daigo, Y, Huang, H-E, Iyer, N G, Callagy, G, Kranjac, T, Gonzalez, M, Sangan, T, Earl, H, Caldas, C
Publicado em 2003

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received

Por Dawson, S-J, Makretsov, N, Blows, F M, Driver, K E, Provenzano, E, Le Quesne, J, Baglietto, L, Severi, G, Giles, G G, McLean, C A, Callagy, G, Green, A R, Ellis, I, Gelmon, K, Turashvili, G, Leung, S, Aparicio, S, Huntsman, D, Caldas, C, Pharoah, P
Publicado em 2010

Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study

Por Balmativola, D., Marchiò, C., Maule, M., Chiusa, L., Annaratone, L., Maletta, F., Montemurro, F., Kulka, J., Figueiredo, P., Varga, Z., Liepniece-Karele, I., Cserni, G., Arkoumani, E., Amendoeira, I., Callagy, G., Reiner-Concin, A., Cordoba, A., Bianchi, S., Decker, T., Gläser, D., Focke, C., van Diest, P., Grabau, D., Lips, E., Wesseling, J., Arisio, R., Medico, E., Wells, C., Sapino, A.
Publicado no Breast Cancer Res Treat (2014)